- Oops!Something went wrong.Please try again later.
NEW YORK, Sept. 27, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Oak Street Health, Inc. (“Oak Street” or the “Company”) (NYSE: OSH). Such investors are advised to contact Robert S. Willoughby at email@example.com or 888-476-6529, ext. 7980.
The investigation concerns whether Oak Street and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On September 16, 2020, post-market, Oak Street issued a press release announcing the Company’s financial and operating results for the second quarter of 2020. Among other results, Oak Street’s announcement reported a quarterly loss of $72.53 per share, missing by a significant margin the $0.16 per share loss expected by analysts.
On this news, Oak Street’s stock price fell $1.62 or 3.90%, to close at $39.89 on September 17, 2020.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.
Robert S. Willoughby
888-476-6529 ext. 7980